La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), an investigational product to treat conditions characterized by iron overload. The company was founded in 1989 and is headquartered in San Diego, California.
Show more...
執行長
員工
59
國家
US
ISIN
US5034596040
WKN
000A1XB6B
上市
0 Comments
分享你的想法
FAQ
La Jolla Pharmaceutical 今天的股價是多少?▼
LJPC 目前價格為 $6.22 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 La Jolla Pharmaceutical 股價表現。
La Jolla Pharmaceutical 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,La Jolla Pharmaceutical 的股票以代號 LJPC 進行交易。
La Jolla Pharmaceutical 的市值是多少?▼
今天 La Jolla Pharmaceutical 的市值為 170.98M
La Jolla Pharmaceutical 有多少名員工?▼
截至 April 01, 2026,公司共有 59 名員工。
La Jolla Pharmaceutical 位於哪個產業?▼
La Jolla Pharmaceutical從事於Manufacturing產業。
La Jolla Pharmaceutical 何時完成拆股?▼
La Jolla Pharmaceutical 上次拆股發生於 January 14, 2014,比例為 1:50。